A Phase 1 study to assess the effects of MM402 in participants with and without ASD

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  1009997

• Contact name

  Claudia Hernandez

• Contact email

  chernandez@mindmed.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Research summary

  Publication of this data is currently deferred.

• REC name

  Wales REC 1

• REC reference

  24/WA/0124

• Date of REC Opinion

  25 Sep 2024

• REC opinion

  Further Information Unfavourable Opinion